| Literature DB >> 25431125 |
Chinedu Charles Nwafor, Ivana Gribaudo, Anna Schneider, Ron Wehrens, Maria Stella Grando, Laura Costantini1.
Abstract
BACKGROUND: Seedless grapes are greatly appreciated for fresh and dry fruit consumption. Parthenocarpy and stenospermocarpy have been described as the main phenomena responsible for seedlessness in Vitis vinifera. However, the key genes underpinning molecular and cellular processes that play a significant role in seed development are not well characterized. To identify important regulators and mechanisms that may be altered in the seedless phenotype, we performed a comprehensive transcriptional analysis to compare the transcriptomes of a popular seeded wine cultivar (wild-type) and its seedless somatic variant (mutant) at three key developmental stages.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25431125 PMCID: PMC4301461 DOI: 10.1186/1471-2164-15-1030
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1The eighteen relevant categories of triplets of significance. A red line indicates a significant up-regulation, a blue line a significant down-regulation, and a gray dashed line a non-significant difference between time points (the first position in the triplet corresponds to the shift from stage E-L 15 to E-L 27, the second position to the shift from stage E-L 27 to E-L 38 and the third position to the shift from stage E-L 15 to E-L 38). All DE genes for both the wild-type and the mutant formed 18 groups of differential expression patterns and the numbers of genes that fell within each group are shown in Table 3. Group 1 contains positively regulated genes along the whole time course; groups 2 and 3 consist of induced genes from stage E-L 15 to stage E-L 27, with no significant change afterwards; groups 4, 5 and 6 contain induced genes from stage E-L 15 to stage E-L 27, followed by a significant decrease in their expression; groups 7, 8 and 9 consist of stable genes from stage E-L 15 to stage E-L 27, with induced expression from stage E-L 15 or E-L 27 to stage E-L 38. Groups 10, 11 and 12 are made up of stable genes from stage E-L 15 to stage E-L 27 with reduced expression from stage E-L 15 or E-L 27 to stage E-L 38; groups 13, 14 and 15 contain repressed genes from stage E-L 15 to stage E-L 27, followed by a significant induction in their expression; groups 16 and 17 contain repressed genes from stage E-L 15 to stage E-L 27, with no significant subsequent change; group 18 contains negatively regulated genes along the whole time course.
Number of genes in each group of differential expression patterns for the wild-type and the mutant
| Number of groups | Gene pattern | Number of genes (Wild-type) | Number of genes (Mutant) |
|---|---|---|---|
| 1 | 111 | 0 | 0 |
| 2 | 101 | 13 | 4 |
| 3 | 100 | 155 | 112 |
| 4 | 1-11 | 0 | 0 |
| 5 | 1-10 | 21 | 15 |
| 6 | 1-1-1 | 1 | 0 |
| 7 | 011 | 66 | 26 |
| 8 | 010 | 30 | 25 |
| 9 | 001 | 58 | 4 |
| 10 | 00-1 | 34 | 0 |
| 11 | 0-10 | 101 | 118 |
| 12 | 0-1-1 | 131 | 3 |
| 13 | −111 | 0 | 0 |
| 14 | −110 | 2 | 4 |
| 15 | −11-1 | 0 | 0 |
| 16 | −100 | 240 | 319 |
| 17 | −101 | 88 | 4 |
| 18 | −1-1-1 | 2 | 0 |
Figure 2Gene expression overlap between the three key developmental stages in wild-type and mutant plants. Venn diagrams indicate the overlap of global gene expression signatures identified at stages E-L 15 (single flowers in compact groups), E-L 27 (young berries enlarging) and E-L 38 (berries harvest-ripe) of the wild-type (A) and mutant (B) genotypes.
Comparison of gene expression between the wild-type and the mutant
| Wild-type | Mutant | |||||
|---|---|---|---|---|---|---|
| Developmental stage | E-L 15 | E-L 27 | E-L 38 | E-L 15 | E-L 27 | E-L 38 |
| Genes expressed in all developmental stages in the two clones (common genes) | 22516 | 22516 | 22516 | 22516 | 22516 | 22516 |
| Exclusively uniquely expressed genes for each developmental stage | 183 | 187 | 169 | 190 | 70 | 97 |
| Non-detected expression for each developmental stage | 1145 | 1224 | 2108 | 1082 | 1733 | 2841 |
| Constitutively non-expressed genes in the two clones | 565 | 565 | 565 | 565 | 565 | 565 |
Figure 3Comparison of differential gene expression in the pairwise comparison of developmental stages in wild-type and mutant plants. Venn diagrams indicate overlap of all differentially expressed genes obtained from each pairwise comparison between developmental stages (E-L 15 vs E-L 27, E-L 27 vs E-L 38 and E-L 15 vs E-L 38) in wild-type (A) and mutant (B).
Evaluation of significantly up- and down-regulated genes in each pairwise comparison between developmental stages
| Wild-type | Mutant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pairwise comparison | E-L 27 vs E-L 15 | Percentage | E-L 38 vs E-L 27 | Percentage | E-L 38 vs E-L 15 | Percentage | E-L 27 vs E-L 15 | Percentage | E-L 38 vs E-L 27 | Percentage | E-L 38 vs E-L 15 | Percentage |
| Down-regulated genes | 332 | 63.6 | 256 | 72.3 | 256 | 65.1 | 327 | 71.4 | 136 | 71.2 | 34 | 82.9 |
| Up-regulated genes | 190 | 36.4 | 98 | 27.7 | 137 | 34.9 | 131 | 28.6 | 55 | 28.8 | 7 | 17.1 |
| Total | 522 | 354 | 393 | 458 | 191 | 41 | ||||||
Figure 4Quantitative real-time PCR validation of RNA-Seq data. Relative expression profile of 14 genes shows the expression fold change (FC) in the pairwise comparison between developmental stages for the wild-type and the mutant. Histograms represent expression fold changes as assessed by real-time PCR (by using REST), data are reported as means ± SE of three technical replicates (left axis). Green lines represent expression fold changes as assessed by RNA-Seq (by using DESeq, right axis). Blue column with error bar corresponds to the first biological replicate, while red column corresponds to the second biological replicate on which RNA sequencing was carried out.
Candidate genes for seed content that have altered expression in the wild-type and the mutant
| Gene ID | Wild-type gene expression (RPM) | Mutant gene expression (RPM) | Wild-type fold change | Mutant fold change | Gene enrichment | Annotation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E-L 15 | E-L 27 | E-L 38 | E-L 15 | E-L 27 | E-L 38 | E-L 27 vs E-L 15 | E-L 38 vs E-L 27 | E-L 38 vs E-L 15 | E-L 27 vs E-L 15 | E-L 38 vs E-L 27 | E-L 38 vs E-L 15 | |||
| Non-DE genes specific to the wild-type | ||||||||||||||
| VIT_09s0002g01980 | 0.5 | 0.7 | 0.2 | 0 | 0 | 0 | Myosin-like protein XIK | |||||||
| VIT_15s0048g01070 | 0.01 | 0.01 | 1.2 | 0 | 0 | 0 | Vacuolar iron transporter 1 | |||||||
| VIT_04s0044g01520 | 0 | 0.8 | 0 | 0 | 0 | 0 | GA 20-oxidase 2 | |||||||
| VIT_08s0058g01200 | 0 | 0.4 | 0 | 0 | 0 | 0 | sig | Alpha-expansin 2 | ||||||
| Non-DE genes specific to the mutant | ||||||||||||||
| VIT_13s0106g00290 | 0 | 0 | 0 | 0.01 | 0 | 0.1 | Histone deacetylase HDA14 | |||||||
| VIT_03s0088g00900 | 0 | 0 | 0 | 0 | 0.1 | 0.01 | Pathogenesis-related protein 1B | |||||||
| VIT_14s0006g00050 | 0 | 0 | 0 | 0.1 | 0 | 0 | Transposase, IS4 | |||||||
| Common genes differentially regulated in wild-type and mutant | ||||||||||||||
| VIT_01s0026g01680 | 0.02 | 24.6 | 0 | 0.01 | 1.9 | 0 | 1,133 | 0 | nd | 172.5 | nd | nd | sig | Pectate lyase |
| VIT_05s0020g04850 | 1.0 | 2.4 | 89.1 | 0.9 | 0.9 | 101.8 | nd | nd | 113.1 | nd | 153.3 | nd | sig | H1flk |
| VIT_15s0021g02700 | 0.3 | 7.4 | 1,103 | 0 | 2.0 | 1,396 | nd | nd | 4,154 | inf | nd | nd | sig | Beta-expansin (EXPB4) |
| VIT_15s0048g00510 | 9.1 | 170.5 | 4.4 | 8.8 | 74.9 | 2.4 | 18.8 | nd | nd | 8.7 | nd | nd | Pectinesterase family | |
| VIT_15s0021g02170 | 631.1 | 3.1 | 0.3 | 81.4 | 0.2 | 0.4 | 0.005 | nd | 0.0006 | 0.003 | nd | nd | Chalcone and stilbene synthase | |
| VIT_18s0089g00140 | 40.7 | 0.2 | 2.7 | 3.5 | 0 | 8.0 | 0.004 | nd | nd | 0 | nd | nd | 1,4-beta-mannan endohydrolase | |
| VIT_19s0015g00960 | 150.2 | 0.7 | 0 | 59.3 | 0.1 | 0.1 | 0.004 | nd | 0 | 0.002 | nd | nd | ABC transporter G member 4 | |
| VIT_18s0001g01760 | 969.1 | 8.1 | 0.04 | 854.3 | 3.2 | 1.0 | 0.008 | nd | 0.00005 | 0.004 | nd | nd | PISTILLATA (PI) floral homeotic protein | |
| VIT_18s0001g13460 | 107.1 | 13.8 | 0 | 84.4 | 7.9 | 0.1 | 0.1 | nd | 0 | 0.1 | nd | nd | MADS-box AP3 | |
| Differentially expressed genes specific to the wild-type | ||||||||||||||
| VIT_01s0011g06390 | 29.9 | 0.4 | 0.01 | 3.2 | 0.4 | 0.04 | 0.01 | nd | 0.0004 | nd | nd | nd | sig | MALE STERILITY 1 |
| VIT_08s0007g07100 | 20.5 | 0.8 | 0.02 | 3.7 | 0.06 | 0.04 | 0.04 | nd | nd | nd | nd | nd | sig | MALE STERILITY 2 |
| VIT_07s0005g05680 | 17.6 | 0.2 | 3.5 | 4.0 | 0.2 | 0.04 | 0.009 | nd | nd | nd | nd | nd | MALE STERILITY 5 | |
| VIT_07s0005g05720 | 29.3 | 1.6 | 2.3 | 14.5 | 2.6 | 1.2 | 0.06 | nd | nd | nd | nd | nd | MALE STERILITY 5 | |
| VIT_15s0107g00550 | 172.2 | 19.7 | 21.8 | 111.7 | 26.7 | 2.5 | 0.1 | nd | nd | nd | nd | nd | sig | MALE STERILITY 5 |
| VIT_19s0014g03940 | 7.7 | 0.2 | 0.06 | 4.5 | 0.3 | 0.06 | 0.02 | nd | nd | nd | nd | nd | SPOROCYTELESS | |
| VIT_12s0142g00040 | 49.6 | 2.6 | 0.07 | 12.5 | 0.7 | 0.08 | 0.05 | nd | 0.002 | nd | nd | nd | Glycerol-3-phosphate acyltransferase 1 | |
| VIT_00s1404g00010 | 17.5 | 22.6 | 0.04 | 18.1 | 14.6 | 0.04 | nd | 0.002 | nd | nd | nd | nd | sig | Calmodulin-binding |
| VIT_01s0026g01420 | 22.2 | 58.8 | 0.3 | 22.8 | 57.2 | 0.2 | nd | 0.007 | nd | nd | nd | nd | Wall-associated kinase 4 | |
| VIT_06s0061g00730 | 406.0 | 887.8 | 0.3 | 423.5 | 1,138 | 0.2 | nd | 0.0004 | 0.0009 | nd | nd | nd | Aquaporin GAMMA-TIP3/TIP1;3 | |
| VIT_18s0001g13200 | 31.7 | 143.9 | 0.3 | 38.7 | 110.9 | 0.5 | nd | 0.003 | nd | nd | nd | nd | Cytokinin dehydrogenase 5 precursor | |
| VIT_05s0094g00330 | 0.9 | 16.2 | 969.7 | 0.9 | 4.2 | 712.2 | 17.6 | nd | 1,332 | nd | nd | nd | Chitinase, class IV | |
| VIT_10s0003g03030 | 0.02 | 6.5 | 0.4 | 0.06 | 0.5 | 0.6 | 300.4 | nd | nd | nd | nd | nd | Cation/hydrogen exchanger (CHX15) | |
| VIT_01s0011g01560 | 0.2 | 14.2 | 0.07 | 0.4 | 2.4 | 0.07 | 72.6 | nd | nd | nd | nd | nd | TRANSPARENT TESTA16 | |
| VIT_18s0001g03010 | 0 | 1.5 | 0 | 0 | 0.2 | 0 | inf | nd | nd | nd | nd | nd | BZIP transcription factor | |
| VIT_18s0041g01880 | 9.5 | 67.4 | 33.2 | 9.8 | 10.7 | 26.7 | 7.1 | nd | nd | nd | nd | nd | sig | MADS-box protein SEEDSTICK |
| VIT_03s0038g04340 | 0.2 | 6.9 | 0.07 | 0.3 | 0.6 | 0.2 | 33.7 | nd | nd | nd | nd | nd | FERONIA receptor-like kinase | |
| VIT_17s0000g08110 | 1.1 | 23.1 | 0.01 | 0.2 | 1.4 | 0 | 20.1 | 0.0006 | nd | nd | nd | nd | Nodulin MtN3 | |
| VIT_17s0000g09000 | 0.8 | 0.4 | 36.3 | 0.5 | 0.009 | 0.04 | nd | 125.8 | nd | nd | nd | nd | Oleosin OLE-2 | |
| VIT_07s0151g00640 | 12.4 | 5.2 | 453.2 | 17.9 | 3.0 | 1.1 | nd | 109.3 | nd | nd | nd | nd | Globulin-1 S allele precursor | |
| VIT_14s0128g00200 | 0.04 | 0.1 | 42.5 | 0.09 | 0 | 0 | nd | 540.1 | 1,242 | nd | nd | nd | 7S globulin precursor | |
| VIT_13s0067g01250 | 0.06 | 0.1 | 26.0 | 0.02 | 0 | 0 | nd | 330.4 | 506.5 | nd | nd | nd | Em protein GEA6 (EM6) | |
| VIT_14s0108g00520 | 0 | 0.2 | 89.3 | 0.03 | 0.09 | 0.03 | nd | 637.6 | inf | nd | nd | nd | Protease inhibitor/seed storage/lipid transfer protein (LTP) | |
| VIT_16s0039g00220 | 0.4 | 0.2 | 25.2 | 0.3 | 0.1 | 0.7 | nd | 192.0 | nd | nd | nd | nd | Aquaporin BETA-TIP | |
| VIT_07s0005g05400 | 0 | 0.08 | 22.1 | 0.05 | 0 | 0 | nd | 360.2 | inf | nd | nd | nd | ABSCISIC ACID-INSENSITIVE protein 3 (ABI3) | |
| VIT_19s0014g04130 | 0.7 | 0.2 | 23.6 | 0.3 | 0.4 | 6.4 | nd | 179.8 | nd | nd | nd | nd | Serine/threonine-protein kinase receptor ARK3 | |
| VIT_18s0001g01570 | 0.2 | 0.5 | 265.1 | 0.3 | 0.07 | 0.3 | nd | 631.3 | 1,548 | nd | nd | nd | Seed maturation protein PM31 | |
| VIT_14s0128g00340 | 0.1 | 0.08 | 17.0 | 0.1 | 0 | 0 | nd | 277.3 | nd | nd | nd | nd | Seed maturation protein PM34 | |
| VIT_04s0008g01610 | 0 | 0.3 | 176.8 | 0 | 0 | 0 | nd | 776.9 | inf | nd | nd | nd | Heat shock protein 17.6 kDa class II | |
| Differentially expressed genes specific to the mutant | ||||||||||||||
| VIT_14s0219g00270 | 20.3 | 2.5 | 0.08 | 21.6 | 0.5 | 0.08 | nd | nd | nd | 0.03 | nd | nd | TEL1 (Terminal EAR1-like 1) | |
| VIT_12s0059g00560 | 14.6 | 1.1 | 1.1 | 17.8 | 0.6 | 0.4 | nd | nd | nd | 0.04 | nd | nd | Fimbrin 2 | |
| VIT_04s0008g04980 | 15.5 | 2.7 | 0.2 | 10.1 | 0.3 | 0.06 | nd | nd | nd | 0.03 | nd | nd | Boron transporter-like protein 4 | |
| VIT_09s0002g01670 | 9.0 | 1.1 | 0.03 | 11.8 | 0.09 | 0 | nd | nd | nd | 0.007 | nd | nd | Myb domain protein 26 | |
| VIT_09s0002g01370 | 13.2 | 1.3 | 0.2 | 14.0 | 0.3 | 0 | nd | nd | nd | 0.02 | nd | nd | AP2 AINTEGUMENTA | |
| VIT_14s0006g02950 | 25.4 | 12.6 | 37.4 | 53.1 | 5.4 | 123.3 | nd | nd | nd | 0.1 | nd | nd | LATERAL ORGAN BOUNDARIES protein 41 | |
| VIT_15s0046g03080 | 3.4 | 0.9 | 0.02 | 2.9 | 0 | 0 | nd | nd | nd | 0 | nd | nd | DTA2 (downstream target of AGL15 2) | |
| VIT_12s0134g00240 | 17.7 | 36.7 | 21.5 | 9.7 | 77.1 | 22.7 | nd | nd | nd | 8.1 | nd | nd | Avr9/Cf-9 rapidly elicited protein 20 | |
| VIT_12s0028g03270 | 14.2 | 30.5 | 48.0 | 7.3 | 62.5 | 55.7 | nd | nd | nd | 8.8 | nd | nd | Ethylene-responsive transcription factor 9 | |
| VIT_16s0013g00950 | 1.8 | 5.1 | 2.1 | 1.1 | 22.1 | 0.4 | nd | nd | nd | 20.5 | nd | nd | Ethylene-responsive transcription factor ERF105 | |
| VIT_16s0013g00990 | 2.4 | 5.0 | 0.7 | 1.2 | 18.6 | 0.4 | nd | nd | nd | 16.1 | nd | nd | Ethylene-responsive transcription factor ERF105 | |
| VIT_16s0013g01050 | 3.1 | 6.3 | 1.1 | 1.8 | 23.3 | 0.3 | nd | nd | nd | 13.2 | nd | nd | Ethylene-responsive transcription factor ERF105 | |
| VIT_16s0013g01120 | 3.2 | 13.2 | 63.7 | 3.1 | 29.5 | 49.1 | nd | nd | nd | 9.8 | nd | nd | Ethylene-responsive transcription factor ERF105 | |
Abbreviations : nd not detected in a pairwise comparison, inf infinity (when the mean of one stage in a pairwise comparison is the denominator with value 0), sig significant.